| RS2147142645 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147143428 |
CNKSR2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2147143992 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147144038 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 2 |
| RS2147144049 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147144421 |
FRMPD4
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 104 |
| RS2147145062 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2147145500 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147145565 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147145603 |
CDKL5
|
Health Risk |
Likely pathogenic |
CDKL5 disorder, CDKL5 disorder |
| RS2147145614 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147145827 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2147147064 |
PIGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2147147959 |
CDKL5
|
Health Risk |
Likely pathogenic |
— |
| RS2147147996 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147148013 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147148016 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 2 |
| RS2147148032 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147148055 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147148081 |
CDKL5
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS2147148092 |
CDKL5
|
Health Risk |
Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147148112 |
LOC126863186;PPP6R2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS2147151004 |
TANC2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2147151260 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS2147153521 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147153531 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147154554 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2147154613 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2147154755 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2147154765 |
EBP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147154775 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2147154777 |
EBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2147155759 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2147156094 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147156107 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147156191 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147156320 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2147156501 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2147156561 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2147157078 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2147160087 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147160115 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147160162 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147160237 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147160283 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147160726 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147160749 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147160886 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147160920 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS2147160942 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147161009 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147161299 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147161353 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147163808 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2147164011 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147164144 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147164191 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147164417 |
PI4KA
|
Health Risk |
Likely pathogenic |
Polymicrogyria, perisylvian |
| RS2147164676 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS2147164710 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS2147164893 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2147165095 |
TLK2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2147165727 |
TLK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 57 |
| RS2147167432 |
CLCN4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 49 |
| RS2147167570 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147167604 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147168097 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS2147168716 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2147169894 |
RBM10
|
Health Risk |
Likely pathogenic |
— |
| RS2147170755 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2147171118 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147171155 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147171181 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147171209 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147171210 |
PI4KA
|
Health Risk |
Pathogenic |
Polymicrogyria, perisylvian |
| RS2147171235 |
USP9X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 99 |
| RS2147172268 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2147173819 |
CLCN4
|
Health Risk |
Pathogenic |
— |
| RS2147174157 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2147174292 |
FRMPD4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147174336 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147174436 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147174461 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147174479 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147174526 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147174569 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2147174604 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147174618 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2147175251 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2147175318 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2147175359 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS2147175548 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147175902 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS2147176072 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2147176325 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2147176710 |
DMD
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2147176806 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2147177179 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147177201 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2147177418 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |